| Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome … S Ramiro, RLM Mostard, C Magro-Checa, CMP van Dongen, T Dormans, ... Annals of the rheumatic diseases 79 (9), 1143-1151, 2020 | 254 | 2020 |
| Management of neuropsychiatric systemic lupus erythematosus: current approaches and future perspectives C Magro-Checa, EJ Zirkzee, TW Huizinga, GM Steup-Beekman Drugs 76, 459-483, 2016 | 233 | 2016 |
| A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility FD Carmona, SL Mackie, JE Martín, JC Taylor, A Vaglio, S Eyre, ... The American Journal of Human Genetics 96 (4), 565-580, 2015 | 190 | 2015 |
| GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways E López-Isac, M Acosta-Herrera, M Kerick, S Assassi, AT Satpathy, ... Nature communications 10 (1), 4955, 2019 | 132 | 2019 |
| Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites E Ercan, C Magro-Checa, R Valabregue, F Branzoli, ET Wood, ... Brain 139 (5), 1447-1457, 2016 | 74 | 2016 |
| Antibodies against carbamylated proteins and cyclic citrullinated peptides in systemic lupus erythematosus: results from two well-defined European cohorts M Ziegelasch, MAM van Delft, P Wallin, T Skogh, C Magro-Checa, ... Arthritis research & therapy 18, 1-11, 2016 | 68 | 2016 |
| Calcium pyrophosphate crystal deposition disease: diagnosis and treatment JL Rosales-Alexander, J Balsalobre Aznar, C Magro-Checa Open access rheumatology: research and reviews, 39-47, 2014 | 68 | 2014 |
| Demyelinating disease in SLE: is it multiple sclerosis or lupus? CM Checa, D Cohen, ELEM Bollen, MA van Buchem, TWJ Huizinga, ... Best Practice & Research Clinical Rheumatology 27 (3), 405-424, 2013 | 66 | 2013 |
| Value of multidisciplinary reassessment in attribution of neuropsychiatric events to systemic lupus erythematosus: prospective data from the Leiden NPSLE cohort C Magro-Checa, EJ Zirkzee, LJJ Beaart-van de Voorde, HA Middelkoop, ... Rheumatology 56 (10), 1676-1683, 2017 | 63 | 2017 |
| A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus E Ercan, C Ingo, O Tritanon, C Magro-Checa, A Smith, S Smith, ... NeuroImage: Clinical 8, 337-344, 2015 | 63 | 2015 |
| Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus V Torrente-Segarra, TC Salman-Monte, Í Rúa-Figueroa, S Pérez-Vicente, ... Clin Exp Rheumatol 34 (2 Suppl 96), S40-S47, 2016 | 61 | 2016 |
| Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis A Serrano, A Márquez, SL Mackie, FD Carmona, R Solans, ... Annals of the rheumatic diseases 72 (11), 1882-1886, 2013 | 60 | 2013 |
| Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of … E López‐Isac, JE Martín, S Assassi, CP Simeón, P Carreira, ... Arthritis & rheumatology 68 (9), 2338-2344, 2016 | 53 | 2016 |
| C1q deficiency and neuropsychiatric systemic lupus erythematosus RA Van Schaarenburg, C Magro-Checa, JA Bakker, YKO Teng, ... Frontiers in immunology 7, 647, 2016 | 48 | 2016 |
| EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19 A Alunno, A Najm, PM Machado, H Bertheussen, GR Burmester, ... Annals of the rheumatic diseases 80 (6), 698-706, 2021 | 47 | 2021 |
| Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life RC Monahan, LJJ Beaart-Van De Voorde, GM Steup-Beekman, ... Lupus 26 (12), 1252-1259, 2017 | 47 | 2017 |
| Laboratory and neuroimaging biomarkers in neuropsychiatric systemic lupus erythematosus: where do we stand, where to go? C Magro-Checa, GM Steup-Beekman, TW Huizinga, MA Van Buchem, ... Frontiers in medicine 5, 340, 2018 | 45 | 2018 |
| Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study C Fernández‐Carballido, MA Martín‐Martínez, C García‐Gómez, ... Arthritis Care & Research 72 (6), 822-828, 2020 | 44 | 2020 |
| Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis A Ferreiro-Iglesias, A Montes, E Perez-Pampin, JD Cañete, E Raya, ... The pharmacogenomics journal 16 (2), 137-140, 2016 | 44 | 2016 |
| Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer RJH Martens, AJ van Adrichem, NJA Mattheij, CG Brouwer, DJL van Twist, ... Clinical Chemistry and Laboratory Medicine (CCLM) 59 (4), 783-793, 2021 | 42 | 2021 |
T.W.J. HuizingaLeiden University Medical CenterVerified email at lumc.nl
